Tackling healthcare challenges: funding competition 30 March 2017
30th March 2017
Innovate UK has launched its latest funding competition, as part of the Biomedical Catalyst scheme. This may be of interest to clients in the healthcare field.
The Biomedical Catalyst has up to £12 million to support innovative healthcare technologies and processes that could help to prevent disease or better manage and treat chronic health conditions.
They are seeking projects across a range of fields including:
• stratified healthcare (both therapy and diagnostic components)
• advanced therapies (cell and gene therapy)
• digital health
• enabling medical technologies and devices
Funding is available for late-stage awards and could be for projects including:
• initial human proof-of-concept studies
• demonstration of clinical utility and effectiveness
• demonstration of safety and efficacy (including phase I and II clinical trials)
• developing production mechanisms
• market testing
• intellectual property protection
• the competition opens on 30 March 2017, and the deadline for registration is midday on 31 May 2017
• projects must be led by an SME either working alone or with others
• projects are expected to range in size from £250,000 to £4 million and to last between 12 and 36 months
• businesses could attract up to 70% of their project costs
• a briefing event for potential applicants takes place on 4 April 2017
Compulsory licensing of pharmaceuticals
26th September 2019
As the Supreme Court’s Judgment that the government’s suspension of parliament was unlawful made headlines, Jeremy Corbyn – the leader of the Opposition – used his speech at the Labour Party conference to announce radical policies.